{
    "startDate": "2021-01-01",
    "endDate": "2021-06-30",
    "year": "2021",
    "quarter": "Q2",
    "symbol": "CBLI",
    "data": {
        "bs": [
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 13823780
            },
            {
                "label": "Total Cytocom, Inc. stockholders\u2019 equity (deficit)",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": 8569489
            },
            {
                "label": "Accumulated other comprehensive loss",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": -681820
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 60503
            },
            {
                "label": "Short-term investments",
                "concept": "ShortTermInvestments",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 13776955
            },
            {
                "label": "Total liabilities and stockholders\u2019 equity",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 13828734
            },
            {
                "label": "Accrued expenses",
                "concept": "AccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 240120
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -170301633
            },
            {
                "label": "Preferred stock, $.005 par value; 1,000,000 shares authorized as of June 30, 2021 and December 31, 2020; 0 shares issued and outstanding as of June 30, 2021 and December 31, 2020",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Common stock, $.005 par value; 25,000,000 shares authorized as of June 30, 2021 and December 31, 2020; 15,468,945 and 13,376,062 shares issued and outstanding as of June 30, 2021 and December 31, 2020",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 77340
            },
            {
                "label": "Total stockholders\u2019 equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 13528111
            },
            {
                "label": "Total stockholders\u2019 equity",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": 13528111
            },
            {
                "label": "Other current assets",
                "concept": "OtherAssetsCurrent",
                "unit": "usd",
                "value": 46825
            },
            {
                "label": "Equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 4954
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 179475602
            },
            {
                "label": "Noncontrolling interest in stockholders\u2019 equity",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 4958622
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 300623
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 13828734
            }
        ],
        "cf": [
            {
                "label": "Sale of short-term investments",
                "concept": "ProceedsFromSaleOfHeldToMaturitySecurities",
                "unit": "usd",
                "value": 323111
            },
            {
                "label": "Change in value of warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": ""
            },
            {
                "label": "Change in value of warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -1223547
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -1214299
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -1214299
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -1214299
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 3077
            },
            {
                "label": "Effect of exchange rate change on cash and equivalents",
                "concept": "EffectOfExchangeRateOnCashAndCashEquivalents",
                "unit": "usd",
                "value": 7685
            },
            {
                "label": "Accrued liability extinguishment",
                "concept": "cbli:GainLossOnExtinguishmentOfContingentLiabilities",
                "unit": "usd",
                "value": ""
            },
            {
                "label": "Purchase of short-term investments",
                "concept": "PaymentsToAcquireHeldToMaturitySecurities",
                "unit": "usd",
                "value": ""
            },
            {
                "label": "Net cash provided by investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": 323111
            },
            {
                "label": "Issuance of common stock, net of offering costs",
                "concept": "cbli:ProceedsFromIssuanceOfCommonStockAndWarrants",
                "unit": "usd",
                "value": 12723288
            },
            {
                "label": "Other long-term assets",
                "concept": "IncreaseDecreaseInOtherNoncurrentAssets",
                "unit": "usd",
                "value": ""
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 12723288
            },
            {
                "label": "Increase in cash and cash equivalents",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 11830537
            },
            {
                "label": "Exercise of warrants",
                "concept": "ProceedsFromWarrantExercises",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Accounts payable and accrued expenses",
                "concept": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities",
                "unit": "usd",
                "value": -8553
            },
            {
                "label": "Accounts receivable and other current assets",
                "concept": "cbli:IncreaseDecreaseInAccountsReceivableAndOtherCurrentAssets",
                "unit": "usd",
                "value": 3772
            }
        ],
        "ic": [
            {
                "label": "Foreign exchange gain (loss)",
                "concept": "ForeignCurrencyTransactionGainLossBeforeTax",
                "unit": "usd",
                "value": -10
            },
            {
                "label": "Net loss attributable to common stockholders per share of common stock, basic and diluted (in dollars per share)",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -0.08
            },
            {
                "label": "Grants and contracts",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total operating expenses",
                "concept": "OperatingExpenses",
                "unit": "usd",
                "value": 1220499
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -1220499
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 169773
            },
            {
                "label": "Net loss attributable to Cytocom, Inc.",
                "concept": "NetIncomeLoss",
                "unit": "usd",
                "value": -1197604
            },
            {
                "label": "Change in value of warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": ""
            },
            {
                "label": "Change in value of warrant liability",
                "concept": "FairValueAdjustmentOfWarrants",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -1214299
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -1214299
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -1214299
            },
            {
                "label": "Net loss attributable to noncontrolling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -16695
            },
            {
                "label": "Weighted average number of shares used in calculating net loss per share, basic and diluted (in shares)",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 14847980
            },
            {
                "label": "Total other income (expense)",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": 6200
            },
            {
                "label": "Interest and other income (expense)",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 6210
            },
            {
                "label": "General and administrative",
                "concept": "GeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 1050726
            },
            {
                "label": "Foreign currency translation adjustment",
                "concept": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": 5712
            },
            {
                "label": "Comprehensive loss including noncontrolling interests",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -1208587
            },
            {
                "label": "Net loss including noncontrolling interests",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -1214299
            },
            {
                "label": "Net loss including noncontrolling interests",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -1214299
            },
            {
                "label": "Net loss including noncontrolling interests",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -1214299
            },
            {
                "label": "Comprehensive loss attributable to Cytocom, Inc.",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -1193744
            },
            {
                "label": "Comprehensive loss attributable to noncontrolling interests",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -14843
            }
        ]
    }
}